These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28434044)

  • 1. Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.
    Pagliarini V; La Rosa P; Sette C
    Hum Genet; 2017 Sep; 136(9):1215-1235. PubMed ID: 28434044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splice-switching antisense oligonucleotides as therapeutic drugs.
    Havens MA; Hastings ML
    Nucleic Acids Res; 2016 Aug; 44(14):6549-63. PubMed ID: 27288447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of aberrant splicing in human RNA diseases by chemical compounds.
    Kataoka N
    Hum Genet; 2017 Sep; 136(9):1237-1245. PubMed ID: 28364159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Diverse Functional and Regulatory Consequences of Alternative Splicing in Development and Disease.
    Titus MB; Chang AW; Olesnicky EC
    Front Genet; 2021; 12():775395. PubMed ID: 34899861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3.
    Rawcliffe DF; Österman L; Lindsten H; Holmberg M
    PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of alternative splicing to muscle type development and function.
    Nikonova E; Kao SY; Spletter ML
    Semin Cell Dev Biol; 2020 Aug; 104():65-80. PubMed ID: 32070639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of RNA splicing in the pathogenesis of spinal muscular atrophy and development of its therapeutics].
    Sahashi K; Sobue G
    Brain Nerve; 2014 Dec; 66(12):1471-80. PubMed ID: 25475034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [RNA pathologies in neurological disorders].
    Ohno K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):801-4. PubMed ID: 18210802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions.
    Singh NN; Lee BM; Singh RN
    Ann N Y Acad Sci; 2015 Apr; 1341():176-87. PubMed ID: 25727246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases.
    Veltrop M; Aartsma-Rus A
    Exp Cell Res; 2014 Jul; 325(1):50-5. PubMed ID: 24486759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing intervention for Duchenne muscular dystrophy.
    McClorey G; Fletcher S; Wilton S
    Curr Opin Pharmacol; 2005 Oct; 5(5):529-34. PubMed ID: 16085461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor splicing pathway is not minor any more: implications for the pathogenesis of motor neuron diseases.
    Onodera O; Ishihara T; Shiga A; Ariizumi Y; Yokoseki A; Nishizawa M
    Neuropathology; 2014 Feb; 34(1):99-107. PubMed ID: 24112438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemistry of mitochondrial encephalomyopathy].
    Ozawa T; Tanaka M
    No To Shinkei; 1990 Aug; 42(8):707-17. PubMed ID: 2223265
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog.
    Crawford Parks TE; Ravel-Chapuis A; Bondy-Chorney E; Renaud JM; Côté J; Jasmin BJ
    Hum Mol Genet; 2017 May; 26(10):1821-1838. PubMed ID: 28369467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering targeting rules of splicing modulator compounds: case of TG003.
    Sakuma M; Iida K; Hagiwara M
    BMC Mol Biol; 2015 Sep; 16():16. PubMed ID: 26400733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephalopathy, petechiae, and acrocyanosis with ethylmalonic aciduria associated with muscle cytochrome c oxidase deficiency.
    García-Silva MT; Campos Y; Ribes A; Briones P; Cabello A; Santos Borbujo J; Arenas J; Garavaglia B
    J Pediatr; 1994 Nov; 125(5 Pt 1):843-4. PubMed ID: 7965445
    [No Abstract]   [Full Text] [Related]  

  • 17. Muscular dystrophies and other genetic myopathies.
    Shieh PB
    Neurol Clin; 2013 Nov; 31(4):1009-29. PubMed ID: 24176421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic therapies for RNA mis-splicing diseases.
    Hammond SM; Wood MJ
    Trends Genet; 2011 May; 27(5):196-205. PubMed ID: 21497936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy.
    Sanaker PS; Toompuu M; Hogan VE; He L; Tzoulis C; Chrzanowska-Lightowlers ZM; Taylor RW; Bindoff LA
    Biochim Biophys Acta; 2010 Jun; 1802(6):539-44. PubMed ID: 20206689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.